Health
Ping An Good Doctor Launches Groundbreaking 'Private Doctor' Service
Strategic Move to Introduce Customized Mobile Medical Services SHANGHAI, June 10, 2019 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited("Ping An Good Doctor", or the "Company"; stock code: 01833.HK), the world's leading one-stop healthcare ecosystem platform, has launched the...
2019-06-10 12:32
9151
Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks
Abstracts 54-OR and 55-OR Secondary data at 52 weeks demonstrated statistically significant blood sugar reductions and statistically significant reduction of body weight vs both Jardiance® and Victoza® SAN FRANCISCO, June 8, 2019 /PRNewswire/ -- Findings presented today from two phase 3a clinic...
2019-06-08 23:45
2966
ESPGHAN Researchers Warn: Junk Food Could Be Responsible for the Food Allergy Epidemic
GLASGOW, Scotland, June 8, 2019 /PRNewswire/ -- Experts at the 52nd Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) are today presenting research that shows higher levels of advanced glycation end products (AGEs), found in abundance in ju...
2019-06-08 07:01
4574
Asia's Leading Companies Celebrated at the 2019 Frost & Sullivan Asia-Pacific Best Practices Awards
SINGAPORE, June 7, 2019 /PRNewswire/ -- Frost & Sullivan named some of Asia's leading companies recognized for their achievements in its recipients list for the Asia-Pacific Best Practices Awards earlier today. Mr. Shivaji Das, Partner & Asia-Pacific Managing Director at Frost & Sullivan noted t...
2019-06-07 23:23
10168
Global Cord Blood Corporation Announces Formation of a Special Committee to Evaluate Non-Binding Proposal
HONG KONG, June 6, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that in response to the non-binding proposal l...
2019-06-06 18:00
15882
HealthEngine celebrates new milestone for Australian health, recording one million bookings in a single month
PERTH, Australia, June 6, 2019 /PRNewswire/ -- HealthEngine
2019-06-06 09:21
5828
Yichun to boost tourism industry development in Jiangxi
YICHUN, China, June 5, 2019 /PRNewswire/ -- The 2019 Jiangxi Tourism Industry Development Conference opened in Yichun City, East China'sJiangxi province on June 5. The annual event is an important platform for tourism cooperation of Jiangxi Province. Yichun, one of the most picturesque citi...
2019-06-05 18:31
4492
Poor Oral Health Severely Impacts Training and Athletic Performance, Says FDI World Dental Federation
GENEVA, June 5, 2019 /PRNewswire/ -- If they want to win, elite and amateur
athletes need to make theiroral health
2019-06-05 09:00
2880
Innovent provides Update on the Results of Sintilimab for the Treatment of Extranodal NK/T Cell Lymphoma by Oral Presentation at ASCO
SUZHOU, China, June 5, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the research data on the treatment of relapsed or refractory extranodal NK/T cell ly...
2019-06-05 08:00
5887
Cellenkos, Inc. Initiates Phase 1 Clinical Trial of CK0801 for Treatment of Bone Marrow Failure Syndromes
HOUSTON, June 4, 2019 /PRNewswire/ -- Cellenkos, Inc., announced today the initiation of a Phase 1 Clinical Trial of CK0801, a first-in-class, allogeneic cord blood-derived T-regulatory cell product, for treatment of patients with bone marrow failure syndromes, including aplastic anemia, hypoplas...
2019-06-04 21:17
5734
RemeGen, Ltd. Announces Positive Results from RC48 Clinical Trial in HER2-Positive Metastatic or Unresectable Urothelial Cancer
Results, presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, demonstrated clinically meaningful response in patients with urothelial carcinoma whose treatment previously failed, a population with high unmet medical need YANTAI, China, June 4, 2019 /PRNewswire/ -- R...
2019-06-04 21:00
5807
Global Cord Blood Corporation Announces Receipt of Preliminary Non-Binding Proposal to Acquire the Company
HONG KONG, June 4, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that its board of directors has received a no...
2019-06-04 20:17
16772
Medtec China will expand to 2 Halls in 2020 for the first time
SHANGHAI, June 4, 2019 /PRNewswire/ -- Medtec China 2019 will be held at Shanghai World Expo Exhibition and Convention Center September 25–27. This exhibition has continued its upward momentum trend -- the overall scale of the event is up by21%, and the area of exhibition booths commercially avai...
2019-06-04 19:11
6058
Genecare partners with Jupiter Chain to release a secure online genetic profiling platform
SINGAPORE, June 4, 2019 /PRNewswire/ -- Genetics testing is the core of preventive healthcare. Clients must first understand their genetic makeup to lower the risks of developing an illness or disease. A leading ASEAN company, Genecare, is one genetics testing company that allows clients to bette...
2019-06-04 09:00
4601
Innovent Provides Update on Sintilimab in Combination with CAPOX for First-Line Treatment of Patients with Gastric or Gastroesophageal Junction Carcinoma (GC/GEJC)
SUZHOU, China, June 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the preliminary results of efficacy and safety of sintilimab, the anti-PD-1 antibody...
2019-06-04 08:00
10731
Innovent Provides Updates on Extended Follow-up on Sintilimab for Relapsed/Refractory Classical Hodgkin's Lymphoma
SUZHOU, China, June 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the results of extended follow-up on sintilimab, the anti-PD-1 antibody that co-deve...
2019-06-04 08:00
10266
Innovent Provides Update on ctDNA in Predicting Response and Resistance by Anti-PD-1 Therapy in Chinese Relapsed/Refractory Classical Hodgkin Lymphoma
SUZHOU, China, June 3, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced that the results of circulating tumor DNA (ctDNA) for predicting response and resistance ...
2019-06-04 08:00
3486
Merck Presents Updated Results for Investigational Therapy Tepotinib Demonstrating Durable Clinical Response in Patients with Advanced NSCLC with METex14 Skipping Mutations
ASCO Abstract # Tepotinib (MET kinase inhibitor): 9005 Not intended for UK- , Canada- or US-based media DARMSTADT, Germany, June 4, 2019 /PRNewswire/ -- * Alterations of the MET signaling pathway are present in 3-5% of non-small cell lung cancer patients and correlate with poor prognosis * N...
2019-06-04 02:16
3082
IMG Announces Start of Annual Leave Your Mark Essay Contest
INDIANAPOLIS, June 4, 2019 /PRNewswire/ -- International Medical Group® (IMG®), an award-winning, global insurance benefits and assistance services company is pleased to announce the start of their third annual Leave Your Mark essay contest, designed to benefit mission organizations around the wo...
2019-06-04 01:02
2053
Frost & Sullivan Publishes Q1 Update on Kadimastem
Continues its plans as expected; Ministry of Health approval for central experiment; financing is required to continue operations at the beginning of 2020; received Orphan Drug Designation from the FDA; target price unchanged. TEL AVIV, Israel, June 3, 2019 /PRNewswire/ -- The TASE analysis proje...
2019-06-03 21:24
1640
Week's Top Stories
Most Reposted
Troy Animal Healthcare Strengthens Quality Operations with Veeva Vault Quality
[Picked up by 325 media titles]
2024-05-17 07:00Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
[Picked up by 319 media titles]
2024-05-15 12:00
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
[Picked up by 306 media titles]
2024-05-16 15:00
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
[Picked up by 276 media titles]
2024-05-16 09:39
Trip.com Group and Rezdy Join Forces to Offer New Travel Experiences Around the World
[Picked up by 229 media titles]
2024-05-14 18:07Most Read
Ultima Markets Recognised as Most Popular Broker 2024 by BrokersView
2024-05-15 12:00
11042
Home to half of the world's top 10 trending tourism destinations, Asia Pacific is making a comeback: Mastercard Economics Institute on travel in 2024
2024-05-16 15:00
9485
US-BASED PANDUIT ELEVATES MANUFACTURING LANDSCAPE WITH NEW STATE-OF-THE-ART PLANT IN JOHOR BAHRU, MALAYSIA
2024-05-16 09:39
8967
Casio to Release G-SHOCK-Surfrider Foundation Collaboration
2024-05-15 09:00
8270
Traveloka strengthens sustainability pledge as world's first Platinum Sponsor of GSTC
2024-05-13 16:42
7515
